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active vasculitis, on the basis of three arguments: (1)
immunosuppressive medications increase the risk of infection
regardless of ESRD; (2) rates of death should take into
consideration duration of follow up; (3) comparison of causes
of death between ESRD and non-ESRD patients should take
into account the state of disease activity.
The goal of maintenance immunosuppressive therapy in
patients in remission is to decrease the risk of relapse.
Decisions regarding maintenance therapy must consider the
relative risks and beneﬁts of such therapy (risk/beneﬁt ratio).
Considering that the incidence of relapse was signiﬁcantly
lower after ESRD (0.08 episodes/person-year) compared with
the same patients before ESRD (0.2 episodes/person-year,
P¼ 0.0012), there is little potential beneﬁt of maintenance
immunosuppression after ESRD.
In describing the major causes of death in the ESRD
population, our goal was to highlight the frequency of infec-
tions, especially among immunosuppressed patients. Although
active vasculitis was a major cause of death in the ﬁrst month
after diagnosis, infection accounted for 50% of deaths beyond
then. Not surprisingly, infections were more frequent among
patients receiving immunosuppressants compared with those
who were not (1.94 vs 1.03 episodes/person-year, Po0.0001). In
aggregate, the high rate of serious infections coupled with the
low rate of relapse suggest that ESRD patients without active
vasculitis are more likely to suffer from severe or fatal infections
than relapsing disease. Therefore, the risk/beneﬁt ratio does not
support the routine use of maintenance immunosuppression
therapy in antineutrophil cytoplasmic autoantibody small vessel
vasculitis patients on chronic dialysis.
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CRRT in series with extracorporeal
membrane oxygenation
in pediatric patients
To the Editor: We read with great interest the article by
Santiago et al.1 describing an institutional method of
performing continuous renal replacement therapy (CRRT),
using a dedicated machine in series with extracorporeal
membrane oxygenation (ECMO) in pediatric patients. We
previously described the same method with some important
differences,2 and subsequently evaluated the technical and
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Figure 1 | Schematic representation of continuous hemofiltration circuit in parallel and countercurrent to cardiopulmonary circuit.
CRRT, continuous renal replacement therapy; ECMO, extracorporeal membrane oxygenation.
Kidney International (2010) 77, 468–472 469
l e t t e r to the ed i to r
clinical efﬁcacy of this system.3,4 In the last 3 years, we treated
15 patients with ECMO and CRRT. In contrast to the setup
suggested by the authors, we connected the ﬁlter inlet
of the CRRT machine after the ECMO pump, and the ﬁlter
outlet was then returned to the ECMO circuit before the
pump (into the reservoir, if present): The CRRT circuit,
running counter-current to extracorporeal assistance, allows
the blood to be infused into the venous ECMO section
(where the patient is drained) and then to be aspired from the
arterial ECMO section (where blood returns to the patient)
(Figure 1). In our opinion, there are several reasons to prefer
this setup. First, ECMO connection lines are generally used
for circuit pressure monitorization, and frequently one
connection in the ECMO venous line and one in the arterial
line remain available. Second, this might reduce blood ﬂow
resistance and turbulence after the centrifugal pump and
improve reservoir drainage when a roller pump is present.
Blood recirculation induced by this circuit setup is negligible,
considering that the CRRT to ECMO blood ﬂow ratio is
never 40.1. The only requirement to take into consideration
during roller extracorporeal assistance is to increase ECMO
blood ﬂow by the same amount as CRRT blood ﬂow, to
compensate the shunted circulation. Interestingly, during
centrifugal ECMO, the ﬂow is self-adjusted to the increased
value, considering the additional pre-pump blood ﬂow coming
from the CRRT circuit and reduced resistances after the
centrifuge due to blood aspiration into the dialysis machine.
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The Authors Reply: After having read Dr Ricci et al.’s1
comments about our article,2 we would like to add some
considerations.
The papers published by these authors are single-case
descriptions that basically refer to the working of the
continuous renal replacement therapy (CRRT). In these
papers no assessment of CRRT and extracorporeal membrane
oxygenation (ECMO) working in-line was carried out.3,4 On
the contrary, our study evaluates these characteristics in vitro,
in an animal model as well as in children, through a clinical
prospective study.2
Similar to our model, Ricci et al. connect the ﬁlter inlet of
the CRRT machine after the ECMO pump, but the ﬁlter
outlet is returned to the ECMO circuit before the pump (into
the reservoir, if present). The authors suggest that this type of
connection may have some advantages:
(1) One connection in the ECMO venous line and one in the
arterial line are available. However, this depends on the
type of ECMO circuit used. In our type of circuit, the
CRRT device is connected through a three-way luer lock
connection that allows measurement of the pressure and
the infusion of heparin simultaneously in the same line.
This also makes the connection and withdrawal of the
circuit easy at any time without causing any alteration in
the ECMO function.
(2) This might also reduce blood flow resistance and
turbulence after the centrifugal pump and improve
reservoir drainage when a roller pump is present. We are
not aware of any study having measured the turbulence
and resistance to blood flow or suction pressures in the
reservoir after the connection of the CRRT to the ECMO
circuit, but the effect is likely to be minimum because, as
the authors say, the CRRT to ECMO blood flow ratio is
never greater than 0.1.
So, what disadvantages might the connection that Dr Ricci
et al. propose have? As the ECMO pump exerts a negative
pressure in the reservoir and/or the circuit, which could be
transmitted to the CRRT device and could cause errors in the
outlet pressure, as well as decrease in the ﬁlter pressure and
transmembrane pressure, important information regarding
the state of the ﬁlter could be lost.
In conclusion, connecting the CRRT device to the ECMO
circuit improves the handling of the CRRT device.
Probably there is no unique method to connect these
devices, and each institution must assess and decide on
which method to adopt depending on the circuit and machine
they use.
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